Quantcast

Latest Diabetic retinopathy Stories

2014-03-06 08:29:58

DALLAS, March 6, 2014 /PRNewswire-iReach/ -- ReportsnReports.com adds "U.S. Market for Diagnostic Opthalmic Devices" & "U.S. Market and Survey for Retinopathy Screening Devices" reports to its research database. (Photo: http://photos.prnewswire.com/prnh/20140306/MN77154) The market for diagnostic ophthalmic devices continues to expand, driven by strong growth in revenue from optical coherence tomographers (OCTs). In 2013, the market for diagnostic ophthalmic devices continued...

2014-03-05 08:28:36

VANCOUVER, March 5, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) has announced the final month eight patient visit in the iDEAL Study. This US Phase 2 investigator-sponsored study is evaluating the efficacy and safety of iCo-007 after repeated injections in patients with Diabetic Macular Edema (DME). The study's primary endpoint is change in visual acuity from baseline to month eight, followed by secondary endpoints at month...

2014-03-03 04:22:41

TARRYTOWN, N.Y., March 3, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA(®) (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare (MHLW). "Clinically significant DME is a leading cause of vision loss in the working-age...

2014-02-24 23:03:11

Weil Eye Care urges patients to get an eye exam during Save Your Vision Month. San Carlos, CA (PRWEB) February 24, 2014 In honor of Save Your Vision Month, Weil Eye Care is offering tips and information on maintaining good eye and vision health. The most important tip to remember is to schedule regular eye exams. Weil Eye Care highly recommends that everyone make an appointment for an eye exam regularly. Getting an eye exam is an essential step in preserving vision and keeping eyes...

2014-02-24 08:27:50

TARRYTOWN, N.Y., Feb. 24, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA(®) (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review of an sBLA is ten months from...

Exercise Can Help Reduce Or Slow Vision Loss
2014-02-12 12:23:58

Brett Smith for redOrbit.com - Your Universe Online While it may seem unrelated to eye function, physical exercise can actually help to protect the structure and function of nerve cells in the retina after injury – according to a new study in The Journal of Neuroscience. The study indicated that exercising may be able to hamper the advancement of retinal degenerative diseases, such as age-related macular degeneration. “This is the first report of simple exercise having a direct...

2014-02-10 08:26:04

TARRYTOWN, N.Y., Feb. 10, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in the Phase 3 VISTA-DME trial of EYLEA(®) (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100, compared to...

2014-02-05 12:28:59

DR. CATHERINE PHAM JOINS HAWAII CATARACT & LASER INSTITUTE KAHULUI, Hawaii, Feb. 5, 2014 /PRNewswire/ -- Hawaii Cataract and Laser Institute's Maui location is pleased to announce Catherine Pham, MD will be joining its Kahului office beginning February 10, 2014. Dr. Pham's arrival to this office opens new opportunities to provide patients with comprehensive eye care without the delay of an appointment. (Photo: http://photos.prnewswire.com/prnh/20140205/LA59337) A board-certified...

2014-01-13 08:26:25

First NHS patient treated less than seven weeks following NICE published guidance ATLANTA, Jan. 13, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has begun shipping initial orders of ILUVIEN® to several United Kingdom National Health Service (NHS) facilities. Additionally, on January 10, 2014, the...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related